The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | C | Cardiovascular system | |
2 | C08 | Calcium channel blockers | |
3 | C08D | Selective calcium channel blockers with direct cardiac effects | |
4 | C08DA | Phenylalkylamine derivatives | |
5 | C08DA01 | Verapamil |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
Route | Amount |
---|---|
ORAL - Oral | 0.24 g |
PAREN - Parenteral | 0.24 g |
Active Ingredient | Description | |
---|---|---|
Verapamil |
Verapamil is a phenylalkylamine calcium antagonist which blocks the inward movement of calcium ions in cardiac muscle cells, in smooth muscle cells of the coronary and systemic arteries and in cells of the intracardiac conduction system. It lowers heart rate, increases myocardial perfusion and reduces coronary spasm. Because of its effect on the movement of calcium in the intracardiac conduction system, verapamil reduces automaticity, decreases conduction velocity and increases the refractory period. |
Title | Information Source | Document Type | |
---|---|---|---|
AKILEN Film-coated tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
ISOPTIN Film‐coated tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
ISOPTIN Solution for injection / infusion | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
SECURON Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
SECURON SR Modified-release tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
VERAPAMIL Film-coated tablets | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.